Intrinsic Value of S&P & Nasdaq Contact Us

Accolade, Inc. ACCD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
40/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.03
+0.1%

Accolade, Inc. (ACCD) has a consensus analyst rating of Hold, based on 20 analysts covering the stock. Of those, 7 recommend buying, 13 recommend holding, and 0 recommend selling.

The analyst consensus price target for ACCD is $7.03, representing a +0.1% upside from the current price of $7.02. Price targets range from a low of $7.03 to a high of $7.03.

Analyst Consensus — ACCD

Hold
Strong Buy
0
Buy
7
Hold
13
Sell
0
Strong Sell
0
20 analysts
Price Targets
Consensus$7.03
High$7.03
Low$7.03
Median$7.03
Last Month Avg-
Last Quarter Avg-
Last Year Avg$7.03
All-Time Count25
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message